Radioimmunotherapy and fractionated radiotherapy of human colon cancer liver metastases in nude mice

Cancer Research

Volumn 57, Issue 3, 1997, Pages 447-453

  Vogel, Charles André ^a,b   Galmiche, Marie C ^a,b   Buchegger, Franz ^c  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^c GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN TC 99M COLLOID; CARCINOEMBRYONIC ANTIGEN MONOCLONAL ANTIBODY; GANGLIOTETRAOSYLCERAMIDE; IMMUNOGLOBULIN G1; IODINE 131;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER TRANSPLANTATION; COLON CANCER; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LIVER METASTASIS; NONHUMAN; NUDE MOUSE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RADIATION DERMATITIS; RADIATION DOSE FRACTIONATION; RADIOIMMUNOTHERAPY; SKIN TOXICITY; SPLENECTOMY;

ANIMALS; COLONIC NEOPLASMS; FEMALE; HUMANS; LIVER NEOPLASMS, EXPERIMENTAL; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; RADIOIMMUNOTHERAPY; RADIOTHERAPY; SURVIVAL RATE; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED;

EID: 0031051143     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Giavazzi, R., Jessup, J. M., Campbell, D. E., Walker, S. M., and Fidler, I. J. Experimental nude mouse model of human colorectal cancer liver metastases. J. Natl. Cancer Inst., 77:1303-1308, 1986.
2. Bresalier, R. S., Raper, S. E., Hujanen, E. S., and Kim, Y. S. A new animal model for human colon cancer metastasis. Int. J. Cancer, 39:625-630, 1987.
3. Jessup, J. M., Giavazzi, R., Campbell, D., Cleary, K. R., Morikawa, K., Hostetter, R., Atkinson, E. N., and Fidler, I. J. Metastatic potential of human colorectal carcinomas implanted into nude mice:prediction of clinical outcome in patients operated upon for cure. Cancer Res., 49: 6906-6910, 1989.
4. Sharkey, R. M., Weadock, K. S., Natale, A., Haywood, L., Aninipot, R., Blumenthal, R. D., and Goldenberg, D. M. Successful radioimmunotherapy for lung metastasis of human colonic cancer in nude mice. J. Natl. Cancer Inst., 83:627-632, 1991.
5. Cheung, N. K., Landmeier, B., Neely, J., Nelson, A. D., Abramowski, C., Ellery, S., Adams, R. B., and Miraldi, F. Complete tumor ablation with iodine 131-radiolabeled disialoganglioside GD2-specific monoclonal antibody against human neuroblastoma xenografted in nude mice. J. Natl. Cancer Inst., 77:739-745, 1986.
6. Senckowitsch, R., Reidel, G., Möllenstäät, S., Kriegel, H., and Pabst, H. W. Curative radioimmunotherapy of human breast tumors with 131-I-labeled monoclonal antibodies. J. Nucl. Med., 30:531-537, 1989.
7. Buchegger, F., Pfister, C., Fournier, K., Prevel, F., Schreyer, M., Carrel, S., and Mach, J-P. Ablation of human colon carcinoma in nude mice by 131-I-labeIed monoclonal anti-careinoembryonic antigen antibody F(ab')2 fragments. J. Clin. Invest., 83:1449-1456, 1989.
8. Buchegger, F., Pèlegrin, A., Delaloye, B., Bischof Delaloye, A., and Mach, J-P. 131-1 labeled F(ab')2 fragments are more efficient and less toxic than intact anti-CEA antibodies in radioimmunotherapy of large human colon carcinoma grafted in nude mice. J. Nucl. Med., 31:1035-1044, 1990.
9. Buchegger, F., Rojas, A., Bischof Delaloye, A., Vogel, C. A., Mirimanoff, R-O., Coucke, P., Sun, L-Q., Raimondi, S., Denekamp, J., Pèlegrin, A.. Delaloye, B., and Mach, J-P. Combined radioimmunotherapy and radiotherapy of human colon carcinoma grafted in nude mice. Cancer Res., 55:83-89, 1995.
10. Schlom, J., Molinolo, A., Simpson, J. F., Siler, K., Roselli, M., Hinkle, G., Houchens, D. P., and Colcher, D. Advantage of dose fractionation in monoclonal antibody-targeted radioimmunotherapy. J. Natl. Cancer Inst., 82:763-771, 1990.
11. Hird, V., Maraveyas, A., Snook, D., Dhokia, B., Soutter, W. P., Meares, C., Stewart, J. S., Mason, P., Lambert, H. E., and Epenetos, A. A. Adjuvant therapy of ovarian cancer with radioactive monoclonal antibody. Br. J. Cancer, 68:403-406, 1993.
12. Chatal, J-F., Douillard, J. Y., and Saccavini, J. C. Clinical prospective study with radioiodinated monoclonal antibodies directed against colorectal cancer. In:R. W. Baldwin and V. S. Byers (eds.), Monoclonal Antibodies for Cancer Detection and Therapy, pp. 159-180. London: Academic Press, 1985.
13. Buchegger, F., Mach, J-P., Pèlegrin, A., Gillet, M., Vogel, C. A., Buclin, T., Ryser, J-E., Delaloye, B., and Bischof Delaloye, A. Radiolabeled chimeric anti-CEA monoclonal antibody compared with the original mouse monoclonal antibody in surgically treated coloreetal carcinoma patients. J. Nucl. Med., 36:420-429, 1995.
14. Halpern, S. E., Haindl, W., Beauregard, J., Hagan, P., Clutter, M., Amox, D., Merchant, B., Unger, M., Mongovi, C., and Bartholomew, R. Scintigraphy with In-111-labeled monoclonal antitumor antibodies: kinetics, biodistribution, and tumor detection. Radiology, 168:529-536, 1988.
15. Emami, B., Lyinan, J., Brown, A., Coia, L., Goitein, M., Munzenrider, J. E., Shank, B., Solin, L. J., and Wesson, M. Tolerance of normal tissue to therapeutic irradiation. Int. J. Radiat. Oncol. Biol. Phys., 21:109-122, 1991.
16. Suit, H. D. Potential for improving survival rates for the cancer patient by increasing the efficacy of treatment of the primary lesion. Cancer (Phila.), 50: 1227-1234, 1982.
17. Order, S. E., Sleeper, A. M., Stillwagon, G. B., Klein, J. L., and Leichner, P. K. Radiolabeled antibodies:results and potential in cancer therapy. Cancer Res., 50 (Suppl.): 1011s-1013s, 1990.
18. Msirikale, J. S., Klein, J. L., Schrocder, J., and Order, S. E. Radiation enhancement of radiolabelled antibody deposition in tumors. Int. J. Radiat. Oncol. Biol. Phys., 13:1839-1844, 1987.
19. Vogel, C. A., Galmiche, M. C., Westermann, P., Sun, L-Q., Pèlegrin, A., Folli, S., Bischof Delaloye, A., Slosman, D. O., Mach, J-P., and Buchegger, F. CEA expression, antibody localization and immunophotodetection of human colon cancer liver metastases in nude mice:a model for radioimmunotherapy. Int. J. Cancer, 67: 295-302, 1996.
20. Rutzky, L. P., Kaye, C. I., Siciliano, M. J., Chao, M., and Kahan, B. D. Longitudinal karyotype and genetic signature analysis of cultured human colon adenocarcinoma cell lines LS180 and LS174T. Cancer Res., 40:1443-1448, 1980.
21. Tibbetts, L. M., Doremus, C. M., Tzanakakis, G. N., and Vezeridis. M. P. Liver metastases with 10 human colon carcinoma cell lines in nude mice and association with carcinoembryonic antigen production. Cancer (Phila.), 71:315-321, 1993.
22. Habu, S., Fukui, H., Shimamura, K., Kasai, M., Nagai, Y., Okumara, K., and Tamaoki, N. Reduction of NK activity and enhancement of transplanted tumor growth in nude mice. J. Immunol., 127:34-38, 1981.
23. Haskell, C. M., Buchegger, F., Schreyer, M., Carrel, S., and Mach, J-P. Monoclonal antibodies to carcinoembryonic antigen: ionic strength as a factor in the selection of antibodies for immunoscintigraphy. Cancer Res., 43:3857-3864, 1983.
24. Hammarstrom, S., Shively, J. E., Paxton, R. J., Beatty, B. G., Larson, A., Ghosh, R., Bormer, O., Buchegger, F., Mach, J-P., Burtin, P., Seguin, P., Darbouret, B., Degorce, F., Sertour, J., Jolu, J-P., Fuks, A., Kalthoff, H., Schmiegel, W., Arndt, R., Kloppel, G., von Kleist, S., Grunert, F., Schwarz, K., Matsuoka, Y., Kuroki, M., Wagener, C., Weber, T., Yachi, A., Imai, K., Hishikawa, N., and Tsujisaki, M. Antigenic sites in carcinoembryonic antigen. Cancer Res., 49:4852-4858, 1989.
25. Bischof Delaloye, A., Delaloye, B., Buchegger, F., Gilgien, W., Studer, A., Curehod, S., Givel, J. C., Mosimann, F., Pettavel, J., and Mach, J-P. Clinical value of immunoscintigraphy in colorectal carcinoma patients:a prospective study. J. Nucl. Med., 30: 1646-1656, 1989.
26. Mach, J-P., Pèlegrin, A., and Buchegger, F. Imaging and therapy with monoclonal antibodies in non-hematopoietic tumors. Curr. Opin. Immunol., 3:685-693, 1991.
27. Buchegger, F., Vacca, A., Carrel, S., Schreyer, M., and Mach, J-P. Radioimmunotherapy of human colon carcinoma by 131-I-labelled monoclonal anti-CEA antibodies in a nude mouse model. Int. J. Cancer, 41:127-134, 1988,
28. Sheldon, P. W., and Hill, S. A. Hypoxic cell radiosensitizers and local control by X-ray of a transplanted tumour in mice. Br. J. Cancer, 35:795-808, 1977.
29. Humm, J. L. Dosimetric aspects of radiolabeled antibodies for tumor therapy. J. Nucl. Med., 27: 1490-1497, 1986.
30. Nahum, A. E., and Babich, J. W. The effect of beta-ray range on tumor control probability in targetted radionuclide therapy. In:Programme and Abstracts of the ninth annual meeting of the European Society of Therapeutic Radiology and Oncology, p. 131. Montecatini Terme, Italy, 1990.
31. O'Donoghue, J. A., Bardiés, M., and Wheldon, T. E. Relationships between tumor size and curability for uniformly targeted therapy with beta-emitting radionuclides, J. Nucl. Med., 36:1902-1909, 1995.
32. Sgouros, G. Radioimmunotherapy of micrometastases: sidestepping the solid-tumor hurdle. J. Nucl. Med., 36: 1910-1912, 1995.
33. Fowler, J. F. Radiobiological aspects of low dose rates in radioimmunotherapy. Int. J. Radiat. Oncol. Biol. Phys., 18:1261-1269, 1990.
34. Hagan, P. L., Halpem, S. E., Dillman, R. O.. Shawler, D. L., Johnson, D. E., Chen, A., Krishnan, L., Frincke, J., Bartolomew, R. M., David, G. S., and Carlo, D. Tumor size:effect on monoclonal antibody uptake in tumor models. J. Nucl. Med., 27:422-427, 1986.
35. Epenetos, A. A., Carr, D., Johnson, P. M., Bodmer, W. F., and Lavender, J. P. Antibody-guided radiolocalisntion of tumours in patients with testicular or ovarian cancer using two radioiodinated monoclonal antibodies to placental alkaline phosphatase. Br. J. Radiol., 59:117-125, 1986.
36. Chatal, J-F., Saccavini, J-C., Gestin, J-F., Thédrez, P., Curtet, C., Kremer, M., Guerreau, D., Nolibé, D., Fumoleau, P., and Guillard, Y. Biodistribution of indium111-labeled OC 125 monoclonal antibody intraperitoneally injected into patients operated on for ovarian carcinomas. Cancer Res., 49:3087-3094, 1989.
37. Okunieff, P., Dois, S., Lee, J., Singer, S., Vaupel, P., Neuringer, L. J., and Beshah, K. Angiogenesis determines blood flow, growth rate, and ATPase kinetics of tumors growing in an irradiated bed:31P and 2H nuclear magnetic resonance studies. Cancer Res., 51: 3289-3295, 1991.
38. 131I-anticarcinoembryonic antigen therapy of LS174T human colon adenocarcinoma spheroids. Cancer Res., 49:3401-3406, 1989.
39. 131iodine-labeled antibody for u colon cancer model. Cancer Res., 55 (Suppl.):5811s-58l6s, 1995.
40. Hale, G., Clark, M. R., Marcus, R., Winter, G., Dyer, M. J. S., Phillips, J. M., Riechmann, L., and Waldmann, H. Remission induction in non-Hodgkin lymphoma with reshaped human monoclonal antibody Cumpath-1H. Lancet, 2:1394-1399, 1988.
41. Herlyn, D., and Koprowski, H. IgG2a monoclonal antibodies inhibit human tumor growth through interaction with effector cells. Proc. Natl. Acad. Sci. USA, 79:4761-4765, 1982.
42. Riethmüller, G., Schneider-Gädicke, E., Schlimok, G., Schmiegel, W., Raab, R., Höffken, K., Gruber. R., Pichlmaier, H., Hirehe, H., Pichlmayr, R., Buggisch, P., and Witte, J. Randomised trial of monoclonal antibody for adjuvant therapy of resected Dukes' C colorectal carcinoma. Lancet, 343; 1177-1183, 1994.